Click on the links below to read recent Press Releases from Active Motif.
- Active Motif and Swift Biosciences partner to develop advancements in epigenetics
Forge Therapeutics and Active Motif to Collaborate
on Epigenetic Research and Drug Discovery
ChemPartner and Active Motif Form an Epigenetic
Biochemical Technology Alliance
Active Motif Acquires SwitchGear Genomics, Inc.
Further Expanding Gene Regulation Product Offerings
Active Motif Acquires Genpathway, Inc.
Further Expanding Epigenetics Product Offerings
Active Motif Awarded SBIR Grant to Develop
Chromatin IP of Clinical Samples
Active Motif Licenses Methylated-CpG Island
Recovery Assay (MIRA) from City of Hope